Skip to main content
×
Home
    • Aa
    • Aa

Measuring Health Outcomes for Older People Using the Sage Database

  • Giovanni Gambassi (a1), Kate L. Lapane (a2), Antonio Sgadari (a1), Francesco Landi (a1), Vincent Mor (a2) and Roberto Bernabei (a1)...
Abstract
ABSTRACT

We establish the potential for outcomes evaluation of a long-term care population-based dataset. Data come from the Health Care Financing Administration's case-mix and quality demonstration project including all Medicare/ Medicaid certified homes of five U.S. states during 1992–1994. Using the Minimum Data Set, we identified nearly 70,000 residents over 65 years of age with congestive heart failure. We provide a preliminary analysis of pharmacotherapy of congestive heart failure and its effects on decline in physical functioning. Functional outcome, expressed as the rate of ADL decline, was improved for patients on combination therapy relative to those on digoxin or ACE-inhibitors alone. The availability of a population-based data set provides a means of evaluating current policies and practices.

RÉSUMÉ

Cet article cherche à établir le potentiel d'évaluation des programmes d'une base de données sur les soins de longue durée dans la communauté. Les données proviennent d'un projet-pilote sur la qualité et la clientèle du Health Care Financing Administration, incluant tous les établissements couverts par Medicare/ Medicaid de cinq états américains entre 1992 et 1994. À l'aide du Minimum Data Set, 70 000 résidents de plus de 65 ans souffrant d'insuffisance cardiaque globale ont été identifiés. L'analyse préliminaire de la pharmacothérapie de l'insuffisance cardiaque globale et de ses effets sur le déclin des fonctions physiques est présentée. L'état des fonctions physiques, mesuré par le taux de déclin des activités instrumentales de la vie quotidienne des patients qui suivent une thérapie combinée s'améliore par rapport à ceux qui prennent seulement de la digoxine ou des inhibiteurs de l'enzyme convertissant l'angiotensine. La disponibilité d'un ensemble de donnees sur la population fournit done une méthode d'évaluation des politiques et des pratiques courantes.

Copyright
References
Hide All
1.Greengross S, Murphy E, Quam L, Rochon P. Aging: a subject that must be at the top of world agendas. BMJ 1997;315:1028–9.
2.Avorn J. Medication use and the elderly: current status and opportunities. Health Affairs Spring 1995;276–86.
3.Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. It's about integrating individual clinical expertise and the best external evidence. BMJ 1996;312:71–2.
4.Sibbald B, Roland M. Why are randomised controlled trials important? BMJ 1998;316:201.
5.Evidence-Based Medicine Working Group. Evidence-Based Medicine. A new approach to teaching the practice of medicine. JAMA 1992;268:2420–5.
6.Levin A. Evidence-based medicine gaining supporters. Ann Intern Med 1998;128:334–6.
7.Charlton BG. Randomized clinical trials: the worst kind of epidemiology? Nature Medicine 1995;1:1101–2.
8.Taubes G. Looking for the evidence in medicine. Science 1996;272:22–4.
9.Feinstein AR, Horwitz RI. Problems in the evidence of evidence-based medicine. Am J Med 1997;103:529–35.
10.Maynard A. Evidence-based medicine: an incomplete method for informing treatment choices. Lancet 1997;349:126–8.
11.Kerridge I, Lowe M, Henry D. Ethics and evidence based medicine. BMJ 1998;316:1151–3.
12.Naylor CD. Grey zone of clinical practice: some limits to evidence-based medicine. Lancet 1995;345:840–2.
13.Knottnerus JA, Dinant GJ. Medicine based evidence, a prerequisite for evidence based medicine. BMJ 1997;315:1109–10.
14.Schneider LS, Olin JT, Lyness SZ, Chui HC. Eligibility of Alzheimer's disease clinic patients for clinical trials. J Am Geriatr Soc 1997;45:923–8.
15.Green J, Britten N. Qualitative research and evidence based medicine. BMJ 1998;316:1230–2.
16.Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992;268:1417–22.
17.Avorn J. Including elderly people in clinical trials, BMJ 1997;315:1033–4.
18.Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997;315:1059.
19.Lye M. Access to advances in cardiology. Lancet 1997;350:1162–3.
20.Evans JG. Evidence-based and evidence-biased medicine. Age-Ageing 1995;24:461–3.
21.Black N. Developing high quality clinical databases: the key to a new research paradigm. BMJ 1997;315:381–2.
22.Hornberger J, Wrone E. When to base clinical policies on observational versus randomized trial data. Ann intern Med 1997;127:697703.
23.Horwitz RI, Viscoli CM, Clemens JD, Sadock RT. Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med 1990;89:630–8.
24.Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215–8.
25.Walker AM. Common language. Pharmacoepidemiol Drug Safety 1996;5:415–8.
26.Engels EA, Spitz MR. PACE-setting research. Lancet 1997;350:677–8.
27.Beers MH, Ouslander JG, Fingold SG, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992;117:684–9.
28.Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994;272:292–6.
29.Rubenstein LZ. An overview of comprehensive geriatric assessment: rationale, history, program models, basic components. In: Rubenstein LZ, Wieland D, Bernabei R, eds. Geriatric assessment technology: the state of the art. Milano, Italia: Kurtis; 1995:1126.
30.Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995;123:195204.
31.Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997;157:1531–6.
32.Bernabei R, Gambassi G, Mor V. The SAGE database: introducing functional outcomes in geriatric pharmaco-epidemiology. J Am Geriatr Soc 1998;46:250–2.
33.Bernabei R, Gambassi G, Lapane K, et al. Characteristics of the SAGE database: a new resource for research on outcomes in long-term care. J Gerontol Med Sci 1999;54:M2533.
34.Morris JN, Hawes C, Fries BE et al. Designing the national resident assessment instrument for nursing homes. Gerontologist 1990;30:293–7.
35.Gambassi G, Landi F, Peng L, et al. Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. Med Care 1998;36:167–79.
36.Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly cancer patients. JAMA 1998;279:1877–82.
37.Gambassi G, Lapane K, Sgadari A, et al. Prevalence, clinical correlates and treatment of hypertension in institutionalized elderly. Arch Intern Med 1998;158:2377–85.
38.Landi F, Gambassi G, Lapane K, et al. Comorbidity and drug use in cognitively impaired elderly living in long-term care. Dement Geriatr Cogn Disord 1998;9:347–56.
39.Minimum Data Set Plus Training Manual. Natick, MA: Eliot Press; 1991.
40.Hawes C, Morris JN, Phillips CD, Mor V, Fries BE, Nonemaker S. Reliability estimates for the Minimum Data Set for Nursing Home Resident Assessment and care screening (MDS) Gerontologist 1995; 2:172–8.
41.Morris JN, Nonemaker S, Murphy K, et al. A commitment to change: revision of the HCFA's RAI. J Am Geriatr Soc 1997;45:1011–6.
42.Sgadari A, Morris JN, Fries BE, et al. Effort to establish the reliability of the RAI. Age Ageing 1997;26:2730.
43.Hawes C, Phillips CD, Mor V, et al. The OBRA-87 nursing home regulations and implementation of the Resident Assessment Instrument: effects on process quality. J Am Geriatr Soc 1997;45:977–85.
44.Fries BE, Hawes C, Morris JN, Phillips CD, Mor V, Park PS. Effect of the national Resident Assessment Instrument on selected health conditions and problems. J Am Geriatr Soc 1997;45:9941001.
45.Mor V, Intrator O, Fries BE, et al. Changes in hospitalization associated with introducing the resident assessment instrument. J Am Geriatr Soc 1997;45:1002–10.
46.Phillips C, Morris JN, Hawes C, et al. Association of the Resident Assessment Instrument (RAI) with changes in function, cognition, and psychosocial status. J Am Geriatr Soc 1997;45:986–93.
47.Morris JN, Fries BE, Mehr DR et al. MDS Cognitive Performance Scale. J Gerontol 1994;49:M17482.
48.Mor V, Branco K, Fleishman J, et al. The structure of social engagement among nursing home residents. J Gerontol 1995;50B:P18.
49.Voelkl JE, Fries BE, Galecki AT. Predictors of nursing home resident's participation in activity programs. Gerontologist 1995;35:4451.
50.Blaum CS, O'Neill EF, Clements KM, Fries BE, Fiatarone MA. Validity of the Minimum Data Set for assessing nutritional status in nursing home residents. Am J Clin Nutr 1997;66:787–94.
51.Williams BC, Li Y, Fries BE, Warren RL. Predicting patient scores between the Functional Independence measure and the Minimum Data Set: development and performance of a FIM-MDS “crosswalk”. Arch Phys Med Rehabil 1997;78:4854.
52.Resnick HE, Fries BE, Verbrugge LM. Windows to their world: the effect of sensory impariments on social engagement and activity time in nursing home residents. J Gerontol Soc Sci 1997;52:S135–44.
53.Resnick NM, Brandeis GH, Baumann MM, Morris JN. Evaluating a national assessment strategy for urinary incontinence in nursing home residents: reliability of the Minimum Data Set and validity of the Resident Assessment Protocol. Neurourol Urodyn 1996;15:583–98.
54.Fried TR, Mor V. Frailty and hospitalization of long-term stay nursing home residents. J Am Geriatr Soc 1997;45:265–9.
55.Hartmaier SL, Sloane PD, Guess HA, Koch GG. The MDS cognition scale: a valid instrument for identifying and staging nursing home residents with dementia using the Minimum Data Set. J Am Geriatr Soc 1994;42:1173–9.
56.Hartmaier SL, Sloane PD, Guess HA, Koch GG, Mitchell CM, Phillips CD. Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination. J Gerontol Med Sci 1995;50:M12833.
57.Frederiksen K, Tariot P, De Jonghe E. Minimum Data Set Plus (MDS+) scores compared with scores from five rating scales. J Am Geriatr Soc 1996;44:305–9.
58.Fries BE, Schneider DP, Foley WJ, Gavazzi M, Burke R, Cornelius E. Refining a case-mix measure for nursing homes: resource utilization groups (RUG-III). Med Care 1994;32:668–85.
59.Fries BE, Mehr DR, Schneider D, Foley WJ, Burke R. Mental dysfunction and resource use in nursing homes. Med Care 1993;31:898920.
60.Master Drug Data Base (MDDB) Documentation manual. Indianapolis, IN: MediSpan Inc.; 1995.
61.Massachussets Extended Care Federation Survey, Certification and Enforcement. The Long-Term Care Survey Regulations, Forms, Intepretative Guidelines. Dedham, MA, 1995.
62.Zinn JS, Mor V. Nursing home special care units: distribution by type, state and facility characteristics. Gerontologist 1994;34:371–7.
63.Banaszak-Holl J, Zinn JS, Mor V The impact of market and organizational characteristics on nursing care facility service innovation: a resource dependency perspective. Health Serv Res 1996;31:97117.
64.Stambler H. The Area Resource File: a brief look. Public Health Reports 1988;103:184–8.
65.Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med 1997;157:2460–4.
66.McDermott MM, Feinglass J, Lee P, et al. Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center. Am Heart J 1997;134:901–9.
67.Rich MW, Brooks K, Luther P. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990–1995. Am Heart J 1998:135:367–72.
68.The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429–35.
69.SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293302.
70.Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995:273:1450–6.
71.Newman J, Ahmed O, Hyngstrom T, et al. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch Intern Med 1997;157:1103–8.
72.Deedwania PC. Underutilization of evidence-based therapy in heart failure. An opportunity to deal a winning hand with ace up your sleeve. Arch Intern Med 1997;157:2409–12.
73.Wennberg JE, Freeman JL, Shelton RM, et al. Hospital use and mortality among Medicare beneficiaries in Boston and New Haven. N Engl J Med 1989:321:1168–73.
74.Wennberg JE. The geography of health care in the United States. In: Wennberg JE, McAndrew Cooper M, eds. The Dartmouth atlas of health care. Chicago, IL: American Hospital Publishing, Inc.; 1996:1135.
75.Philbin EF, Andreaou C, Rocco TA, Lynch LJ, Baker SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996;77:832–8.
76.Raleigh VS. The demographic timebomb. BMJ 1997;315:442–3.
77.Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998;338:1516–20.
78.Kane RL. Improving the quality of long-term care. JAMA 1995;273:1376–80.
79.Institute of Medicine. Health outcomes for older people. JC Feasley, ed. Washington DC: National Academic Press, 1996.
80.Epstein RS, Sherwood LM. From outcomes research to disease management: a guide for the perplexed. Ann Intern Med 1996;124:832–7.
81.Hunter DJ, Fairfield. Disease management. BMJ 1997;314:50–3.
82.Phillips CD, Sloane PD, Hawes C, et al. Effects of residence in Alzheimer disease special care units on functional outcomes. JAMA 1997;278:1340–4.
83.Zimmerman DR, Karon SL, Arling G, et al. Developing and testing of nursing home quality indicators. Health Care Financing Review 1995;16(4):107–27.
84.Berlowitz DR, Brandeis GH, Moskowitz MA. Using administrative databases to evaluate long-term care. J Am Geriatr Soc 1997;45:618–23.
85.Bradley EH, Besdine R. Outcomes-based quality improvement: reducing the data collection burden. J Am Geriatr Soc 1998;46:534–5.
86.Teresi JA, Holmes D. Should MDS data be used for research? Gerontologist 1992;32:148–9.
87.Ouslander JG. Maximizing the Minimum Data Set. J Am Geriatr Soc 1994;42:1212–3.
88.Black D, Bowman C. Community institutional care for frail elderly people. BMJ 1997;315:441–2.
89.Schroll M. Effects of systematic geriatric assessment. Lancet 1997;350:604–5.
90.Steel K. Research on aging: an agenda for all nations individually and collectively. JAMA 1997;278:1374–5.
91.Fries BE, Schroll M, Hawes C, Gilgen R, Jonsson PV, Park P. Approaching cross-national comparisons of nursing home residents. Age Ageing 1997;26(suppl. 2):13–8.
92.Phillips CD, Hawes C, Mor V, Fries BE, Morris JN, Nennstiel ME. Facility and area variation affecting the use of physical restraints in nursing homes. Med Care 1996;34:1149–62.
93.Gatsonis CA, Epstein AM, Newhouse JP, Normand SL, McNeil BJ. Variations in the utilization of coronary angiography for elderly patients with an acute myocardial infarction. Med Care 1995;33:625–42.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Canadian Journal on Aging / La Revue canadienne du vieillissement
  • ISSN: 0714-9808
  • EISSN: 1710-1107
  • URL: /core/journals/canadian-journal-on-aging-la-revue-canadienne-du-vieillissement
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 1 *
Loading metrics...

Abstract views

Total abstract views: 56 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st October 2017. This data will be updated every 24 hours.